Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) Interest Paid (2024 - 2026)

Updated

Evommune's Interest Paid came in at $4,000 for Q1 2026, unchanged from $4,000 a year earlier.

Analysis

Evommune (EVMN) Interest Paid (2024 - 2026) Analysis & Trends

For FY2025, Evommune's Interest Paid was $7,000, down 79.4% from FY2024.

  • Going back by year, Interest Paid was $34,000 in FY2024.
  • The five-year range for quarterly Interest Paid is $3,000 (Q2 2025) to $6,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 283.00 Mn
10 Evommune 285.17 Mn -352.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Jun 30, 2025 3,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 6,000.00
API Access

Evommune Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=EVMN&period=max&api_key=YOUR_API_KEY